The Current Status of Circulating Tumor DNA Utilization in Australasia: A Survey of Thoracic Oncology Group Australasia Members
Despite limited current use, there is strong interest in ctDNA testing for NSCLC in ANZ. Addressing funding, logistical barriers, and clinician education is essential to enabling equitable, widespread adoption of ctDNA into standard lung cancer care.
Authors
- Malinda Itchins (ORCID: https://orcid.org/0000-0002-2741-8250)
- Annie Wong (ORCID: https://orcid.org/0000-0002-6037-8916)
- Yifei Zhu (ORCID: https://orcid.org/0000-0002-7756-2103)
- Danyon Lo
- Deme Karikos
Institutions
- The University of Sydney (AU)
- University of Auckland (NZ)
- Royal North Shore Hospital (AU)
- Nepean Hospital (AU)
- Chris O’Brien Lifehouse (AU)
- Hutt Hospital (NZ)
- Auckland District Health Board (NZ)
- Northern Sydney Local Health District (AU)
- Capital and Coast District Health Board (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1111/ajco.14215
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00